These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2774002)

  • 1. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.
    Divry P; Mathieu M
    Am J Med Genet; 1989 Apr; 32(4):550-1. PubMed ID: 2774002
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.
    Matalon R; Michals K; Sebesta D; Deanching M; Gashkoff P; Casanova J
    Am J Med Genet; 1988 Feb; 29(2):463-71. PubMed ID: 3354621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylaspartic aciduria in Canavan disease: another proof in two infants.
    Yalaz K; Topçu M; Topaloğlu H; Gürçay O; Ozcan OE; Onol B; Renda Y
    Neuropediatrics; 1990 Aug; 21(3):140-2. PubMed ID: 2234319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [N-acetylaspartic aciduria. Clinical, biological and physiopathological study].
    Gay C; Divry P; Macabeo V; Gilly R
    Arch Fr Pediatr; 1991; 48(6):409-13. PubMed ID: 1929728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canavan disease and N-acetylaspartic aciduria.
    Elpeleg ON; Amir N; Barash V; Glick B; Gross-Tsur V; Shachar E; Shapira Y; Tzelnik N
    Neuropediatrics; 1989 Nov; 20(4):238. PubMed ID: 2608171
    [No Abstract]   [Full Text] [Related]  

  • 6. Canavan disease: value of N-acetylaspartic aciduria?
    de Coo IF; Bakkeren JA; Gabreëls FJ
    Neuropediatrics; 1991 May; 22(2):III. PubMed ID: 1857492
    [No Abstract]   [Full Text] [Related]  

  • 7. [Canavan disease or N-acetyl aspartic aciduria: a case report].
    Boughamoura L; Chaabane F; Tilouche S; Chabchoub I; Kabachi N; Tlili K; Yacoub M; Essoussi AS
    Arch Pediatr; 2007 Feb; 14(2):173-6. PubMed ID: 17196380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylaspartic aciduria due to aspartoacylase deficiency--a new aetiology of childhood leukodystrophy.
    Hagenfeldt L; Bollgren I; Venizelos N
    J Inherit Metab Dis; 1987; 10(2):135-41. PubMed ID: 3116332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spongy degeneration of the neuraxis (Canavan-van Bogaert disease) and N-acetylaspartic aciduria.
    Echenne B; Divry P; Vianey-Liaud C
    Neuropediatrics; 1989 May; 20(2):79-81. PubMed ID: 2739878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protracted clinical course for patients with Canavan disease.
    Zelnik N; Luder AS; Elpeleg ON; Gross-Tsur V; Amir N; Hemli JA; Fattal A; Harel S
    Dev Med Child Neurol; 1993 Apr; 35(4):355-8. PubMed ID: 8335152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of N-acetylaspartic acid resulting nitric oxide toxicity induces aspartoacylase mutations and protein interaction to cause pathophysiology seen in Canavan disease.
    Surendran S
    Med Hypotheses; 2010 Dec; 75(6):533-4. PubMed ID: 20673702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical diagnosis of Canavan disease.
    Bartalini G; Margollicci M; Balestri P; Farnetani MA; Cioni M; Fois A
    Childs Nerv Syst; 1992 Dec; 8(8):468-70. PubMed ID: 1288858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylaspartic aciduria in young age.
    Elpeleg ON
    Neuropediatrics; 1992 Apr; 23(2):112. PubMed ID: 1603285
    [No Abstract]   [Full Text] [Related]  

  • 14. Hereditary tyrosinaemia.
    Lancet; 1990 Jun; 335(8704):1500-1. PubMed ID: 1972437
    [No Abstract]   [Full Text] [Related]  

  • 15. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.
    Kaul R; Gao GP; Balamurugan K; Matalon R
    Nat Genet; 1993 Oct; 5(2):118-23. PubMed ID: 8252036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
    Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ
    Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Canavan disease (aspartoacylase deficiency)].
    Kobayashi K; Tsujino S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):118-21. PubMed ID: 11596340
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Rady PL; Penzien JM; Vargas T; Tyring SK; Matalon R
    Eur J Paediatr Neurol; 2000; 4(1):27-30. PubMed ID: 10701101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canavan disease: a review of recent developments.
    Gordon N
    Eur J Paediatr Neurol; 2001; 5(2):65-9. PubMed ID: 11589315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartoacylase deficiency and Canavan disease in Saudi Arabia.
    Ozand PT; Gascon GG; Dhalla M
    Am J Med Genet; 1990 Feb; 35(2):266-8. PubMed ID: 2309767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.